Breast Cancer Clinical Trials

Showing 1061-1080 of 5,597 trials

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

NCT04023110

Investigators will evaluate the safety, tolerability, and feasibility of a risk-guided cardioprotective treatment strategy with carvedilol, as compared to usual care, in breast cancer patients undergoing treatment with doxorubicin, trastuzumab, or the combination.

CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more

Abramson Cancer Center at Penn Medicine68 participantsStarted Aug 2019

Philadelphia, Pennsylvania, United States

Active Not Recruiting

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

NCT02783664

This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels for the different resulting subgroups. This will help the clinical staff to provide better care for patients both medically and psychologically through potential interventions to decrease stress.

Breast Cancer

Medical College of Wisconsin164 participantsStarted Jul 2016

Milwaukee, Wisconsin, United States

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

Related Searches

The COMPASSION Study

PR-CEAL: Community Outreach Engagement Group

CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Physical Exercise on Metabolic Health, Gut Microbiota, Physical Fitness, and Quality of Life in Obese Breast Cancer Survivors

Axillary Nodal Burden in HER2+ and TNBC

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

African Cancer Genome: GMD

An In-situ Detection for MicroRNA

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer

MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer

ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC